Analysts at AlphaValue Have Reiterated their Past ‘Buy’ rating on Shares Smith & Nephew (LON:SN), Set a GBX 1413 Price Objective


Smith & Nephew (LON:SN) Rating Reaffirmed

In an interesting research report made public this morning, AlphaValue reconfirmed their Buy rating on Smith & Nephew (LON:SN) shares. The target PPS gives a possible upside of 22.02% from firm’s last price.

From a total of 16 analysts covering Smith Nephew PLC (LON:SN) stock, 11 rate it a ”Buy”, 1 a “Sell”, and 8 a ”Hold”. This means that 55% of the ratings are positive. The highest target price is GBX 45 while the lowest target price is GBX 15.42. The mean of all analyst targets is GBX 20.03 with a 2.65% above today’s (GBX 1159) stock price. Smith Nephew PLC was the topic of 64 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Numis Securities maintained shares on December 1 with “Add” rating. Morgan Stanley maintained shares with “Underweight” rating and GBX 1074 target share price in a report from a November 11. Barclays Capital maintained SN stock in a recent report from November 25 with “Overweight” rating. Credit Suisse maintained the rating on November 11. Credit Suisse has a “Neutral” rating and a GBX 1105 price target on shares. Finally, BNP Paribas maintained the stock with “Outperform” rating in a report issued on a November 17.

Approximately 665,071 shares of stock traded hands. Smith & Nephew plc (LON:SN) has risen 2.23% since May 6, 2015 and is uptrending. It has outperformed by 2.52% the S&P500.

Analysts at AlphaValue Have Reiterated their Past ‘Buy’ rating on Shares Smith & Nephew (LON:SN), Set a GBX 1413 Price Objective

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The company has a market cap of 10.51 billion GBP. The Firm operates in two divisions: Advanced Surgical Devices and Advanced Wound Management. It has 28 P/E ratio. The Company’s Advanced Surgical Devices segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD).

According to Zacks Investment Research, “Sanchez Energy Corporation is an independent oil and gas exploration and development company focused on the exploration, acquisition and development of unconventional oil and natural gas resources, primarily in the Eagle Ford Shale in South Texas. Sanchez Energy Corporation is headquartered in Houston, Texas.” Get a free copy of the Zacks research report on Smith & Nephew plc (SN).